Item 6. Selected Financial Data.

Five Year Financial Highlights



Years Ended October 31, (In thousands, except per share amounts)	2015		2014		2013		2012		2011
Consolidated Operations
Net sales	$	1,797,060	$	1,717,776	$	1,587,725	$	1,445,136	$	1,330,835
Gross profit	$	1,070,262	$	1,091,570	$	1,026,808	$	924,010	$	804,804
Income before income taxes	$	215,485	$	296,534	$	312,271	$	275,452	$	192,764
Net income attributable to Cooper stockholders	$	203,523	$	269,856	$	296,151	$	248,339	$	175,430
Diluted earnings per share attributable to Cooper stockholders	$	4.14	$	5.51	$	5.96	$	5.05	$	3.63
Number of shares used to compute diluted earnings per share	49,179		48,960		49,685		49,152		48,309
Dividends paid per share	$	0.06	$	0.06	$	0.06	$	0.06	$	0.06
Consolidated Financial Position
Current assets	$	841,818	$	791,617	$	747,241	$	657,860	$	540,347
Property, plant and equipment, net	967,097		937,325		739,867		640,255		609,205
Goodwill	2,197,077		2,220,921		1,387,611		1,370,247		1,276,567
Other intangible assets, net	411,090		453,605		198,769		214,783		128,341
Other assets	43,528		54,872		63,773		58,239		70,058
	$	4,460,610	$	4,458,340	$	3,137,261	$	2,941,384	$	2,624,518
Short-term debt	$	244,193	$	101,518	$	42,987	$	25,284	$	52,979
Other current liabilities	324,979		340,664		278,266		237,268		214,227
Long-term debt	1,105,764		1,280,833		301,670		348,422		327,453
Other liabilities	111,770		146,885		90,844		117,252		92,371
Total liabilities	1,786,706		1,869,900		713,767		728,226		687,030
Stockholders' equity	2,673,904		2,588,440		2,423,494		2,213,158		1,937,488
	$	4,460,610	$	4,458,340	$	3,137,261	$	2,941,384	$	2,624,518

In our fiscal fourth quarter of 2014, Cooper acquired Sauflon Pharmaceuticals Limited, as discussed in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 2 of our notes to consolidated financial statements.

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Previous: Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. · Next: Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.